If a drug exhibits decreased hepatic clearance because of competitive inhibition with another co-administered medication, which consequence follows?

💡 Explanation

When hepatic clearance decreases due to competitive inhibition, the drug's elimination rate slows down, because the liver's capacity to metabolize the drug diminishes, therefore the drug remains in the body longer, leading to an increased plasma half-life, rather than a decreased half-life or altered volume of distribution.

• Why does progressive presbyopia usually develop when individuals maintain prolonged near focus on digital screens, despite using corrective lenses?
• If a patient exhibits elevated blood glucose despite consistently high insulin levels, which consequence affecting the cellular insulin receptors is most likely?
• Why does significant muscle sarcopenia during aging impair glucose tolerance more than simple disuse atrophy?
• Which mechanism causes weakened fracture repair during chronic stress?
• A patient with a genetic defect has impaired cytotoxic T lymphocyte (CTL) function. Why does this deficiency increase the risk of virally induced tumors?
• Why does core body temperature initially rise during heatstroke, despite compensatory mechanisms like sweating and vasodilation?